By Emily Newton – Like many other industries, the medical sector is ramping up its AI adoption. This technology has shown significant potential in many use cases, particularly clinical trials, but some concerns remain. As more organizations use AI in medical research, more ethical questions emerge.
Read More
By Pamela J. Gallagher – The emergence of artificial intelligence is the topic on every healthcare leader’s mind. In many ways, though, AI is old news to those of us in healthcare finance. I can say from experience that once an AI technology comes onto the scene, there is no stopping it. AI is here to stay.
By David Burda – Accuracy is a pillar of healthcare consumerism. It’s the most important pillar. If we want patients and members to make informed decisions about their medical care and their health insurance, they need accurate information to make the right choices for them.
By Anthony Murray – I recently had the pleasure of speaking with Beth Friedman, Senior Partner at FINN Partners, as a guest on the FINN Voices show on Healthcare NOW Radio. The topic was innovation in payer and provider data exchange.
By Matt Fisher – The Office for Civil Rights continues its focus on compliance with the right of access under the HIPAA Privacy Rule. The latest settlement represents the 44th instance since OCR announced the first right of access settlement in 2019.
By Nick Barger, PharmD – You might have heard that the ONC recently released a proposed rule aimed at advancing healthcare through interoperability and technology upgrades. If you’ve been wondering what this means for health IT vendors, we have you covered.
By Devin Partida – Unlike other sectors where nonprofits serve lower-income populations, health care nonprofits usually serve people with higher-than-average incomes and they tend to have strong financial resources. They’re also far more common than for-profit hospitals.
By Karen Youmans MPA RHIA CCS – Healthcare providers can receive incentive payments through value-based programs based on the quality of care provided to Medicare patients. Value-based programs move payments to providers based on quality rather than quantity.
By Patrizia Cavazzoni MD – AI and ML are no longer futuristic concepts; they are now part of how we live and work. The FDA uses the term AI to describe a branch of computer science, statistics, and engineering that uses algorithms or models to perform tasks and exhibit behaviors.